Faulty protein transport associated with ALS
A mutation linked to amyotrophic lateral sclerosis interferes with the transport of proteins in and out of a cell’s nucleus. Targeting this pathway with drugs or therapies may one day help patients with neurodegenerative disease.
New medical students discuss ethical challenges
During orientation, Stanford’s new class of medical students met with deans to pause and reflect on the meaning of pledging their lives to the compassionate care of patients and the challenges involved in achieving that goal.
Rare genes may help mothers, babies
An unusual mutation in an immune system gene switches a receptor from one target molecule to another. It’s the first known example of such a change, say Stanford researchers, and likely leads to safer pregnancies.
Spectrum accepting grant proposals; deadline Sept. 30
Grants of up to $50,000 will be awarded to projects ranging from medical technologies to therapeutics to community engagement.
New clinical trial agreements expedite contract negotiations
The adoption of standardized clinical trial and confidentiality agreements will help reduce the time it takes to get sponsored clinical studies up and running.
5 Questions: Charlotte Jacobs on biography and medicine
The retired Stanford professor’s most recent book, a biography of the polio-vaccine pioneer Jonas Salk, was published in the spring.